colchicine

(redirected from Colcrys)
Also found in: Dictionary, Thesaurus, Medical.
Related to Colcrys: colchicine

colchicine

[′käl·chə‚sēn]
(organic chemistry)
C22H25O6N An alkaloid extracted from the stem of the autumn crocus; used experimentally to inhibit spindle formation and delay centromere division, and medicinally in the treatment of gout.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
"This new partnership will help enhance patient access to an important gout medicine by supplying Prasco with Colchicine Tablets, USP, manufactured under the same rigorous standards and processes as Colcrys."
The addition of URL Pharmaa[euro](tm)s Colcrys to Takedaa[euro](tm)s products will allow the Japanese firm to provide multiple treatment options for the management of acute and chronic gout in the US, where the prevalence of this disease, affecting some eight million people, is growing, Douglas Cole, Takeda Pharmaceuticals USA Inca[euro](tm)s president, said.
After Colcrys came out, and the old cheap colchicine went bye-bye, she tried going with allopurinol alone because of the shocking price of Colcrys.
The FDA's approval of Colcrys and the plans to ban the marketing of the older products has been sharply criticized by some clinicians who treat patients with gout because Colcrys is significantly more expensive than the older, unapproved formulations.
Davis to imply that the results are related to "using the Colcrys formulation," as the Colcrys formulation is colchicine, USP.
Its lead product Colcrys, used to treat and prevent gout flares, had sales of more than $430 million for that year.
50) urged that unapproved, illegally marketed colchicine products remain on the market alongside Colcrys, the only colchicine approved by the Food and Drug Administration.
The recommended treatment for Colcrys is 1.2 mg (two pills, 0.6 mg each) at first sign of flare and 0.6 mg (one pill) one hour later, for a total of three pills total per treatment.
Colchicine (Colcrys) has been used for years to treat gout, and is the first drug to be shown in a double-blind, randomized placebo-controlled trial to prevent recurrent pericarditis.
To that end, Mutual Pharmaceutical Co./URL Pharma performed a clinical trial comparing two dosing regimens for acute gout, did some drug interaction studies in normal volunteers, and branded their previously generic/"unapproved" colchicine product as Colcrys.
is manufacturing colchicine as Colcrys. A combination product that includes colchicine was approved in 1939.